LOW-DOSE ORAL-CONTRACEPTIVE LOWER PLASMA-LEVELS OF LP AL, LP B CIII, LP B E

被引：0
|
作者：
BARKIA, A
STEINMETZ, A
RAYANA, B
ZOUAGHI, H
BARD, JM
FRUCHART, JC
机构：
[1] SERILA INST PASTEUR,F-59019 LILLE,FRANCE
[2] UNIV MARBURG,W-3550 MARBURG,GERMANY
[3] INST NATL NUTR,TUNIS,TUNISIA
来源：
CLINICAL CHEMISTRY | 1990年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：953 / 953
页数：1
相关论文
共 30 条
  • [1] EFFECT ON LIPID-METABOLISM OF A BIPHASIC DESOGESTREL-CONTAINING ORAL-CONTRACEPTIVE - DIVERGENT CHANGES IN APOLIPOPROTEIN B AND E AND TRANSITORY DECREASE IN LP(A) LEVELS
    KUHL, H
    MARZ, W
    JUNGHOFFMANN, C
    WEBER, J
    SIEKMEIER, R
    GROSS, W
    CONTRACEPTION, 1993, 47 (01) : 69 - 83
  • [2] LOW-DOSE ORAL-CONTRACEPTIVES LOWER PLASMA-LEVELS OF APOLIPOPROTEIN-E
    STEINMETZ, A
    BAUER, K
    JURGENSEN, R
    KAFFARNIK, H
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1990, 37 (02): : 155 - 162
  • [3] FIBRINOPEPTIDE A PLASMA-LEVELS DURING LOW-ESTROGEN ORAL-CONTRACEPTIVE TREATMENT
    MELIS, GB
    FRUZZETTI, F
    PAOLETTI, AM
    CARMASSI, F
    FIORETTI, P
    CONTRACEPTION, 1984, 30 (06) : 575 - 583
  • [4] RELATIONSHIP OF PLASMA-LIPOPROTEIN LP(A) LEVELS TO RACE AND TO APOLIPOPROTEIN-B
    GUYTON, JR
    DAHLEN, GH
    PATSCH, W
    KAUTZ, JA
    GOTTO, AM
    ARTERIOSCLEROSIS, 1985, 5 (03): : 265 - 272
  • [5] EFFECT OF A LOW-DOSE ORAL-CONTRACEPTIVE ON SERUM TESTOSTERONE LEVELS IN POLYCYSTIC OVARY DISEASE
    TALBERT, LM
    SLOAN, C
    OBSTETRICS AND GYNECOLOGY, 1979, 53 (06): : 694 - 694
  • [6] ELISA QUANTITATION OF APOLIPOPROTEINS IN PLASMA-LIPOPROTEIN FRACTIONS - APOE IN APO-B-CONTAINING LIPOPROTEINS (LP B-E) AND APO-B IN APOE-CONTAINING LIPOPROTEINS (LP E-B)
    YANG, CY
    XIE, YH
    YANG, ML
    QUION, JA
    GOTTO, AM
    JOURNAL OF PROTEIN CHEMISTRY, 1995, 14 (07): : 503 - 509
  • [7] Apo E phenotype and plasma concentration of apo E and Lp E:B particles in patients with mixed hyperlipoproteinemia
    Dallongeville, J
    Lecerf, JM
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 43 - 44
  • [8] PLASMA-LEVELS OF PROGESTERONE AND ESTROGENS IN WOMEN TREATED WITH AN ORAL-CONTRACEPTIVE OF LOW ESTROGEN CONTENT (OVOSTAT-1375)
    JOHANSSON, EDB
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1975, 54 (03) : 217 - 221
  • [9] COMPARISON OF PLASMA HORMONE CHANGES USING A CONVENTIONAL AND A PAPER PILL FORMULATION OF A LOW-DOSE ORAL-CONTRACEPTIVE
    MORRIS, SE
    SCARISBRICK, JJ
    CAMERON, EHD
    GROOM, GV
    BUCKINGHAM, MS
    EVERITT, J
    ELSTEIN, M
    FERTILITY AND STERILITY, 1978, 29 (03) : 296 - 303
  • [10] CLINICAL INVESTIGATION OF BIOLOGICAL EFFECTS OF A NEW COMBINATION LOW-DOSE ORAL-CONTRACEPTIVE (OVOSTAT-E)
    TARKKILA, T
    HULKKO, S
    ALAPIESSA, U
    KAURANIEMI, T
    CURRENT MEDICAL RESEARCH AND OPINION, 1977, 5 (03) : 247 - 251
123